Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News FDA approves Genentech’s lucentis for comprehensive diabetic retinopathy treatment Genentech, a member of the Roche Group, has received approval from the U.S. Food and Drug Administration (FDA)… bypharmanewsdailyApril 23, 2017
